TuHURA Biosciences, Inc./NV - Common Stock, par value $0.001 per share (HURA)
CUSIP: 898920103
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 66,600,088
- Total 13F shares
- 3,705,458
- Share change
- +219,594
- Total reported value
- $6,624,525
- Price per share
- $1.79
- Number of holders
- 45
- Value change
- +$429,690
- Number of buys
- 28
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 898920103?
CUSIP 898920103 identifies HURA - TuHURA Biosciences, Inc./NV - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 898920103:
Top shareholders of HURA - TuHURA Biosciences, Inc./NV - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13D/G
13F
|
The Vanguard Group · Company |
4.4%
|
2,269,666
|
$5,628,772 | +$87,856 | 30 Sep 2025 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13D/G
|
— |
9.1%
|
6,060,608
|
$4,424,244 | $0 | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
2.4%
|
1,566,364
|
$1,185,268 | — | 31 Dec 2025 | |
| CA Patel F&F Investments, LLC |
13D/G
|
— |
0.9%
|
447,232
|
$1,028,634 | $0 | 12 Jun 2025 | |
| KP Biotech Group LLC |
13D/G
|
— |
0.9%
|
447,232
|
$1,028,634 | $0 | 12 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.99%
|
662,481
|
$501,379 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.43%
|
289,133
|
$218,787 | — | 31 Dec 2025 | |
| Anthony Scott Praill |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
997,533
mixed-class rows
|
$187,714 | — | 01 Aug 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.32%
|
210,402
|
$159,211 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.29%
|
191,636
|
$145,011 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.26%
|
176,197
|
$133,329 | — | 31 Dec 2025 | |
| Alan List |
3/4/5
|
Director |
—
class O/S missing
|
156,240
|
$114,055 | — | 12 Feb 2026 | |
| Craig Tendler |
3/4/5
|
Director |
—
class O/S missing
|
156,240
|
$114,055 | — | 12 Feb 2026 | |
| George K. Ng |
3/4/5
|
Director |
—
class O/S missing
|
156,240
|
$114,055 | — | 12 Feb 2026 | |
| James S. J. Manuso |
3/4/5
|
Director |
—
class O/S missing
|
156,240
|
$114,055 | — | 12 Feb 2026 | |
| Robert E. Hoffman |
3/4/5
|
Director |
—
class O/S missing
|
156,240
|
$114,055 | — | 12 Feb 2026 | |
| Apollon Wealth Management, LLC |
13F
|
Company |
0.2%
|
134,293
|
$101,620 | — | 31 Dec 2025 | |
| Suncoast Equity Management |
13F
|
Company |
0.16%
|
104,409
|
$79,006 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.12%
|
81,920
|
$61,989 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.12%
|
79,816
|
$60,660 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.09%
|
63,007
|
$47,634 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.08%
|
52,615
|
$39,814 | — | 31 Dec 2025 | |
| Saiid Zarrabian |
3/4/5
|
Head of Strategic Partnerships, Director |
—
class O/S missing
|
56,090
|
$37,973 | — | 06 Dec 2021 | |
| Invst, LLC |
13F
|
Company |
0.06%
|
42,506
|
$32,164 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.06%
|
39,093
|
$29,582 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.06%
|
38,208
|
$28,912 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.05%
|
33,575
|
$25,406 | — | 31 Dec 2025 | |
| Hurlow Wealth Management Group, Inc. |
13F
|
Company |
0.05%
|
31,444
|
$23,794 | — | 31 Dec 2025 | |
| Cyndeo Wealth Partners, LLC |
13F
|
Company |
0.05%
|
31,063
|
$23,505 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
28,131
|
$21,295 | — | 31 Dec 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.04%
|
25,500
|
$19,296 | — | 31 Dec 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
23,598
|
$17,860 | — | 31 Dec 2025 | |
| PFG Investments, LLC |
13F
|
Company |
0.04%
|
23,411
|
$17,715 | — | 31 Dec 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.02%
|
16,498
|
$12,485 | — | 31 Dec 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.02%
|
15,440
|
$11,683 | — | 31 Dec 2025 | |
| Merck & Co., Inc. |
13F
|
Company |
0.02%
|
13,950
|
$10,556 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.02%
|
13,773
|
$10,422 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
13,547
|
$10,251 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.02%
|
13,128
|
$10,000 | — | 31 Dec 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.02%
|
10,756
|
$8,139 | — | 31 Dec 2025 | |
| HANCOCK WHITNEY CORP |
13F
|
Company |
0.02%
|
10,627
|
$8,041 | — | 31 Dec 2025 | |
| JOURNEY STRATEGIC WEALTH LLC |
13F
|
Company |
0.02%
|
10,009
|
$7,574 | — | 31 Dec 2025 | |
| CWA Asset Management Group, LLC |
13F
|
Company |
0.02%
|
10,000
|
$7,567 | — | 31 Dec 2025 | |
| Hodges Capital Management Inc. |
13F
|
Company |
0.02%
|
10,000
|
$7,567 | — | 31 Dec 2025 | |
| TT Capital Management LLC |
13F
|
Company |
0.02%
|
10,000
|
$7,567 | — | 31 Dec 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
8,065
|
$6,103 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
7,610
|
$5,758 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
0.01%
|
7,482
|
$5,662 | — | 31 Dec 2025 | |
| Police & Firemen's Retirement System of New Jersey |
13F
|
Company |
0.01%
|
6,029
|
$4,562 | — | 31 Dec 2025 | |
| STRS OHIO |
13F
|
Company |
0.01%
|
4,800
|
$3,632 | — | 31 Dec 2025 |
Institutional Holders of TuHURA Biosciences, Inc./NV - Common Stock, par value $0.001 per share (HURA) as of Q1 2026
As of 31 Mar 2026,
TuHURA Biosciences, Inc./NV - Common Stock, par value $0.001 per share (HURA) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,705,458 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD FIDUCIARY TRUST CO, VANGUARD PORTFOLIO MANAGEMENT LLC, Bank of New York Mellon Corp, Apollon Wealth Management, LLC, Cetera Investment Advisers, Suncoast Equity Management, WealthShield Partners, LLC, and DEUTSCHE BANK AG\.
This page lists
53
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
63
Q1 2026 holders
45
Holder diff
-18
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.